Venmax Drugs And Pharmaceuticals Ltd.

Financial

	Venmax Drugs&Pharma	Saroja Pharma Ind	Parmax Pharma
Operational Metrics
Financials
5 yr Average ROE	-44.32 %	33.33 %	-1624.87 %
5yr average Equity Multiplier	-0.19	4.66	46.04
5yr Average Asset Turnover Ratio	0.32	2.98	0.95
5yr Avg Net Profit Margin	-30.94 %	2.08 %	-9.48 %
Price to Book	3.19	0.0	0.0
P/E	0.0	13.91	0.0
5yr Avg Cash Conversion Cycle	0.0	80.28 Days	-161.05 Days
Inventory Days	24.83 Days	11.27 Days	73.65 Days
Days Receivable	0.0	122.72 Days	40.27 Days
Days Payable	189.56 Days	47.62 Days	328.05 Days
5yr Average Interest Coverage Ratio	-318.36	2.76	1.16
5yr Avg ROCE	-45.33 %	37.65 %	-9.94 %
5yr Avg Operating Profit Margin	-50.41 %	4.76 %	3.93 %
5 yr average Debt to Equity	-0.64	1.78	17.42
5yr CAGR Net Profit	n/a	3.81 %	n/a
5yr Average Return on Assets	187.49 %	6.13 %	-6.43 %
Shareholdings
Promoter Holding	23.13 %	73.02 %	30.8 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	0.0	0.0	0.0
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0